Bowel Endometriosis: Symptoms, Diagnosis, and Treatment

If you've spent years being told your bowel symptoms are just IBS — the cramping, the urgent dashes to the work bathroom, the bloating that makes you look six months pregnant by 3pm — and something has always felt off about that explanation, you're not imagining it. Bowel endometriosis is one of the most commonly missed presentations of endo, partly because its symptoms overlap so convincingly with IBS, and partly because a standard laparoscopy performed by a general gynae can miss it entirely if the surgeon isn't specifically looking for deep infiltrating disease. A 2021 meta-analysis ² found that people with endo have a significantly higher risk of also being diagnosed with IBS compared to those without — which raises a real question about how many of those "IBS" diagnoses were actually endo all along. This article is going to cover what bowel endo actually is (mechanistically, not just "tissue grows in the wrong place"), why it's so hard to diagnose, what imaging can and can't tell you, and what treatment looks like — both hormonal and surgical. There's genuine complexity here, and some of the research is still catching up with what people are experiencing in their bodies. So we'll be honest about what's known, what's emerging, and what nobody has a clean answer to yet. If you've been handed an IBS diagnosis and sent home, or if you already know you have endo and are trying to understand what's happening in your gut specifically, this is for you.

What "bowel endometriosis" actually means

Endo affecting the bowel isn't a separate disease — it's endo that has infiltrated the wall of the bowel itself, typically the rectum or sigmoid colon (the lower sections), though it can affect the small bowel and appendix too. The term you'll see in research is deep infiltrating endometriosis (DIE), and bowel involvement is its most serious presentation. The key word is infiltrating. This isn't just endo sitting on the surface of the bowel — it's growing into the muscular wall, sometimes reaching the inner lining (the mucosa). A 2021 paper ³ describes lesions at the rectosigmoid junction (where the sigmoid colon meets the rectum) as one of the most clinically major locations, because that's where obstruction risk is highest. The depth of infiltration matters enormously — both for symptoms and for surgical planning. Lesions are typically classified by how many millimetres deep they go into the bowel wall, and whether they involve the mucosa or not. This is why a regular pelvic ultrasound by someone who isn't specifically trained in DIE can miss it: you're looking for something that's inside the wall of an organ, not just floating nearby.

Why your gut feels the way it does

Ok so here's what they actually found: endo lesions don't just cause mechanical pressure on the bowel. They trigger a local inflammatory response that affects gut motility, nerve function, and the tissue itself. A 2021 paper ¹ describes how endo lesions cause

The pain caused by endometriosis lesions is variable: some lesions are not painful while other lesions cause neuroinflammation at distance up to 28 mm.

Koninckx PR, Fernandes R, Ussia A, et al. — Pathogenesis Based Diagnosis and Treatment of Endometriosis. Frontiers in endocrinology, 2021. View paper →

from the lesion itself. That's almost three centimetres of tissue being chemically irritated by a single lesion. When that lesion is sitting in or near your bowel wall, you're getting neuroinflammation in the nerves that control gut movement, urgency, and pain signalling. That's not IBS. That's a structural lesion with a measurable inflammatory radius. There's also something happening at the gut microbiome level that researchers are starting to take seriously. A 2023 paper in Fertility and Sterility ⁴ looked at how gut bacteria might actually feed endo lesion growth — specifically an enzyme called β-glucuronidase produced by dysbiotic gut bacteria, which can reactivate oestrogen in the gut and push it back into circulation. This is genuinely emerging territory, not settled science, but it starts to explain why the gut-endo relationship isn't just about one thing pressing on another. Then there's the symptom overlap problem.

Irritable bowel disease and endometriosis are two common diseases characterized by chronic inflammation state and recurrent abdominal pain. As a consequence of sharing of symptoms and chronic inflammation, endometriosis and IBS may coexist and be misdiagnosed and this leads to delays in diagnosis, mismanagement, and unnecessary testing.

Chiaffarino F, Cipriani S, Ricci E, et al. — Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis. Archives of gynecology and obstetrics, 2021. View paper →

². The bloating, the cramping, the alternating constipation and diarrhoea, the pain that's worse around your period — these are textbook IBS symptoms. They're also textbook bowel endo symptoms. Without someone actively looking for endo as the cause, you can spend years on low-FODMAP diets and antispasmodics that help a little but never quite get you there.

Diagnosing it — and why this is genuinely hard

Let's be direct: bowel endo is one of the harder things to diagnose in gynaecology, and the imaging gap is real. Transvaginal ultrasound (TVUS) performed by someone specifically trained in DIE is actually the recommended first-line imaging for suspected bowel endo in most expert centres. A 2018 systematic review and meta-analysis ⁶ comparing TVUS to MRI found that both have reasonable accuracy for detecting DIE — but the key phrase in that paper is "in expert hands." TVUS in a general radiology department by someone who scans thyroids on Tuesday and pelves on Wednesday is not the same as TVUS at a specialist endo centre. MRI is often recommended for surgical planning rather than initial detection — it gives a better picture of the extent of disease, particularly for multi-organ involvement, which matters if you're heading toward surgery. What neither imaging modality does well is definitively rule out bowel endo in someone with strong symptoms. A negative scan at a non-specialist centre doesn't mean no endo. Colonoscopy can miss mucosal-sparing lesions (ones that haven't grown all the way through to the inner lining), which is most of them. So a normal colonoscopy result doesn't rule out bowel endo either. The 2021 paper on medical management ³ recommends that a rectosigmoidoscopy or colonoscopy should be performed before starting hormonal treatment — not to diagnose endo, but to check for obstruction risk and rule out other bowel pathology. Laparoscopy remains the diagnostic tool ¹, but it needs to be performed by a surgeon experienced in DIE. A lap that finds "no endo" when performed by a general gynae who isn't looking at the bowel serosa carefully, or who doesn't have bowel surgical support available, is not a clean bill of health for bowel endo.

Medical (hormonal) management

For people not trying to conceive and without signs of bowel obstruction, hormonal suppression is the first-line approach — and the evidence is actually reasonably encouraging for symptom relief. A 2021 review ³ gives some specific numbers worth knowing: - For endo at the rectosigmoid junction: about 70% chance of intestinal symptom relief with hormonal treatment, about 10% chance of eventually needing surgery after treatment failure, and 1-2% risk of bowel obstruction during treatment.

• For true rectovaginal endo (mid-rectum only): about 80% chance of symptom relief, and about 3% chance of ending up needing surgery.

  Endometriosis infiltrating the bowel can be treated medically in accurately selected women not seeking conception and without overt obstructive symptomatology.

  Vercellini P, Sergenti G, Buggio L, et al. — Advances in the medical management of bowel endometriosis. Best practice & research. Clinical obstetrics & gynaecology, 2021. View paper →

  ³ The hormonal options include progestins (like norethisterone or dienogest), combined hormonal contraceptives, GnRH analogues (like Lupron/Prostap), and newer GnRH antagonists like relugolix (Ryeqo). None of these cure endo — they suppress it by reducing oestrogen and/or progesterone signalling. Symptoms typically return when treatment stops. The choice between them depends on side effect tolerance, contraceptive needs, bone density concerns (relevant for GnRH analogues used long-term), and individual response. This is genuinely a conversation to have with a specialist who knows your imaging and symptom profile — not because "talk to your doctor" is a satisfying answer, but because the decision tree here has real branches that matter.

Surgical treatment

Surgery for bowel endo is serious, and the range of procedures is wide. Options include: - Shaving — removing the lesion from the outer surface of the bowel without entering the bowel lumen. Best for superficial infiltration.

• Disc excision — removing a disc-shaped piece of the bowel wall and closing it. For moderate, localised infiltration.
• Segmental resection — removing a section of bowel and re-joining the ends. For extensive or circumferential disease. A 2021 systematic review and meta-analysis ⁵ of colorectal surgery outcomes for endo found that surgery significantly improves quality of life and pain scores, but also carries real complication risks — including anastomotic leakage, rectovaginal fistula, and bladder dysfunction. These aren't rare enough to wave away. The paper also notes that recurrence rates after surgery are not zero. The decision between shaving, disc excision, and segmental resection is something specialist MDT teams (multidisciplinary — gynaecologist plus colorectal surgeon) debate actively, and the "right" answer depends on lesion size, depth, circumferential involvement, and the surgeon's experience.

What the research actually says

The research on bowel endo has moved forward meaningfully in the last five years, but there are still major gaps — and it's worth being clear about which is which. What the research actually shows: The 2021 meta-analysis on endo and IBS ² pulled together 11 studies and found a consistent pattern:

In recent years, some studies have found higher risk of IBS in women with endometriosis, compared to women without endometriosis.

Chiaffarino F, Cipriani S, Ricci E, et al. — Endometriosis and irritable bowel syndrome: a systematic review and meta-analysis. Archives of gynecology and obstetrics, 2021. View paper →

. The overlap is real and documented. What the research can't yet cleanly answer is how many IBS diagnoses in people with endo are actually misdiagnosed bowel endo versus genuine co-existing IBS versus endo-driven gut dysfunction that presents like IBS. Those are three different things with different implications, and the distinction matters. On the imaging side, the 2018 systematic review ⁶ comparing TVUS and MRI is one of the most cited papers in this space. It found both modalities have diagnostic value for DIE, but both are heavily operator-dependent. The sensitivity and specificity numbers in that paper are from specialist centres — they don't translate directly to what you'll get from a scan at your local hospital unless it has a dedicated endo imaging service. On treatment, the numbers from the 2021 medical management review ³ — 70-80% symptom relief with hormonal suppression, 3-10% eventual surgery rates depending on lesion location — are more concrete than you usually get in endo research. But they come from selected populations (people without obstruction, not trying to conceive), so they're not universally applicable. The gut microbiome angle from the 2023 Fertility and Sterility paper ⁴ is genuinely interesting but should be held lightly. The β-glucuronidase mechanism is plausible and the mouse model data is there, but human clinical evidence for microbiome-targeted treatment in endo is still thin. This is "watch this space" territory, not "go buy probiotics" territory. The surgical data from the 2021 meta-analysis ⁵ confirms that colorectal surgery for endo improves outcomes — but the complication rates in that analysis are a reminder that this is major surgery, and "better outcomes" doesn't mean "no risk." What we don't know yet: We don't have clean data on long-term recurrence after different surgical approaches. We don't know the best duration of hormonal suppression before or after surgery. We don't know whether the microbiome changes in endo are a cause, a consequence, or both. And we don't have a non-invasive diagnostic test that reliably confirms bowel endo without imaging or surgery.

What to do with this

If you're reading this because your gut symptoms have never fully made sense under an IBS framework — especially if they're worse in the week before your period, or if you have painful sex (particularly deep penetration) alongside the bowel symptoms — it's worth specifically pushing for evaluation at a specialist endo centre rather than a general gynaecology clinic. When you do get imaging, ask specifically whether the radiologist or sonographer has experience with DIE and deep infiltrating endo. A standard pelvic ultrasound report that says "normal" is not the same as a dedicated bowel endo assessment. You can ask this directly before the appointment. If you've already been diagnosed with endo and you're having bowel symptoms, ask your specialist whether a rectosigmoidoscopy has been done or is needed — the 2021 review ³ recommends this before starting hormonal treatment, both to check for obstruction and to rule out other bowel pathology. It's a reasonable thing to request. On the hormonal treatment side: if you're being offered suppression therapy for suspected bowel endo, the symptom relief rates in the research ³ are genuinely encouraging — around 70-80% depending on lesion location. It's not nothing. But if you've been on hormonal treatment for months and your bowel symptoms are getting worse rather than better, that's information worth taking back to your specialist. Worsening obstruction symptoms (severe constipation, bloating that's getting progressively worse, vomiting) during hormonal treatment is specifically flagged in the research as something requiring urgent reassessment ³. If surgery is being discussed, ask specifically what procedure is planned (shaving vs disc vs segmental resection), who the colorectal surgeon is, how many of these procedures they do per year, and what the complication rates are at that specific centre. These are not rude questions. They are the right questions. On diet: the gut microbiome research ⁴ is interesting enough that a diet supporting gut diversity (varied fibre, fermented foods, less ultra-processed food) isn't unreasonable — but it's not treatment, and the evidence doesn't yet support specific protocols. Be sceptical of anyone selling a "bowel endo diet" as if it's proven.